| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17e9690b33fea6988d5597b3547ca0d3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17 |
| filingDate |
2019-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b6a96fc83aff69bc4481be167138c2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_120d725b61391da73ad0a520178f9a9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f780a244c0040ef6e2f9fc7a39a1fcd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_952164e0acbf457e2512a8c2a607454e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd8c3d1b38b0bf4d2e1d25a3f47f07ac |
| publicationDate |
2022-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022054544-A1 |
| titleOfInvention |
Conditionally active receptors |
| abstract |
Disclosed herein are conditionally active receptors which comprise a target antigen binding domain and a binding moiety. Each binding moiety comprises non-CDR loops for masking the binding of a target antigen binding domain to its target. The receptors are activated upon cleavage of the cleavable linkers. Pharmaceutical compositions comprising cells comprising the conditionally active receptors disclosed herein and methods of using such formulations are further provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11453716-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11535668-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114478777-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11623958-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11607453-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11661459-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023161853-A1 |
| priorityDate |
2018-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |